The Autorité has fined the companies bioMérieux and Guyane Service Médical for continuing to implement an exclusive import agreement, after the Lurel Act came into force.
regarding practices implemented in the marketing of instruments and reagents for hospital biological laboratories on the French Guyana territory
Presentation of the decision
Dans la décision ci-après, l’Autorité de la concurrence condamne les sociétés bioMérieux SA et Guyane service médical pour avoir, du 22 mars 2013 au 25 août 2016, s’agissant de la première, accordé des droits exclusifs d’importation sur ses produits de biologie médicale et, s’agissant de la seconde, bénéficié de ces droits.
Information about the decision
After several months of investigation and a large public consultation, the Autorité de la concurrence releases the findings of its healthcare sector inquiry
regarding practices implemented in the sector of the online promotion of medical procedures
Presentation of the decision
Information about the decision
The Autorité de la concurrence declines jurisdiction in favour of the administrative judge for the examination of the practices of which the French Medical Council (Conseil de l'Ordre des médecins) and the French Dental Surgeons Council (Conseil de l'Ordre des chirurgiens-dentistes) have accused Groupon
21 September 2018: The European Commission refers two merger operations to the Autorité de la concurrence in the automobile and healthcare establishments sectors.
